Last year in the UK over 60,000 cancer patients enrolled on clinical trials aimed at improving cancer treatments and making them available to all.
A study to develop a quality of life questionnaire for people with blood cancer
This study is for people with a blood cancer such as myeloma, lymphoma or leukaemia.
More about this trial
In this study, the researchers want to find the best way of measuring this.
The aims of this study are to
- find out how symptoms and treatment affect quality of life
- create a new quality of life questionnaire for people with blood cancer
You will not get any direct benefit from taking part in this study. It is unlikely to change your treatment plan in any way. But the researchers hope it will help to develop a better quality of life questionnaire in the future.
Who can enter
You may be able to join this study if all of the following apply. You
- Have cancer of the blood and you are having treatment at the hospital
- Speak and read English well
- Are at least 18 years old
This study is in 2 parts.
- part 1 is the interview stage. The study team need about 100 people to join.
- part 2 is testing the questionnaire the study team develop based on the interviews. The team need over 400 people to join this part.
You have an interview. This takes about half an hour. Each session will be audio recorded. The interviewer will ask you
- your age
- your gender
- about your work
- the type of blood cancer you have
- about symptoms and treatments you have had
The interviewer will talk to you in detail about the impact your cancer has had on your quality of life.
The study team use the information collected in part 1 to develop the new questionnaire. They will test it in various stages to perfect it. So for example to begin with the team need around 60 people to give feedback about the questionnaire
- how easy it is to do
- how relevant the questions are
- whether there are any areas not included which are important
The study team continue to revise and improve the questionnaire with different groups of people. At the end of part 2 they need around 180 people to test the final version.
You have 1 extra visit to hospital to take part in the interview.
There are no side effects from taking part in this study. You may find it uncomfortable to talk issues relating to your cancer. If you do become upset, you can stop the sessions at any time.
How to join a clinical trial
Professor Sam Salek
Experimental Cancer Medicine Centre (ECMC)
European Hematology Association Scientific Working Group
NIHR Clinical Research Network: Cancer